Home > Personal Investment Vitae
Location: United States
Gender: Male
Asset investment style: Quantitative technical analysis
Market capitalization:
$8,936,541talentsVirtual portfolio value:
$5,707,848talentsNet overall return per annum:
19.71%AYA current rank order:
#3Asset investment philosophy:
Jonah Whanau trades U.S. stocks with the top #326 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 65,309 | +681.13% | $235,765 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 3,446 | +589.24% | $141,527 |
| NTZ | Natuzzi S.p.A. | $2.21 | $11.92 | 10,868 | +439.37% | $105,528 |
| MPWR | Monolithic Power Systems Inc. Common Stock | $85.91 | $392.24 | 279 | +356.57% | $85,466 |
| SNPS | Synopsys Inc. Common Stock | $65.98 | $286.79 | 364 | +334.66% | $80,375 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 10,516 | +2,108.33% | $79,816 |
| MED | MEDIFAST INC Common Stock | $43.80 | $178.36 | 548 | +307.21% | $73,739 |
| TUEM | Tuesday Morning Corp. Common Stock | $0.12 | $0.69 | 123,283 | +475.00% | $70,271 |
| MRNS | Marinus Pharmaceuticals Inc. Common Stock | $1.94 | $11.62 | 2,646 | +498.97% | $25,613 |
| BBX | BBX Capital Corporation | $2.54 | $14.54 | 1,682 | +472.44% | $20,184 |
| Sum | $918,284 |
Top 10 current stock portfolio positions as of September 2026Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| PXS | Pyxis Tankers Inc. Common Stock | $6.22 | 16,564 | $103,028 |
| TARS | Tarsus Pharmaceuticals Inc. Common Stock | $83.21 | 1,195 | $99,435 |
| LUMN | Lumen Technologies Inc. Common Stock | $6.91 | 14,206 | $98,163 |
| BLBD | Blue Bird Corporation Common Stock | $63.66 | 1,526 | $97,145 |
| HPQ | HP Inc. Common Stock | $31.93 | 2,957 | $94,417 |
| TCI | Transcontinental Realty Investors Inc. Common Stock | $38.77 | 2,433 | $94,327 |
| DEC | Diversified Energy Company Common Stock | $15.72 | 5,962 | $93,722 |
| SBS | Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) | $5.13 | 18,269 | $93,719 |
| BWXT | BWX Technologies Inc. Common Stock | $160.25 | 583 | $93,425 |
| PRM | Perimeter Solutions SA Common Stock | $32.05 | 2,911 | $93,297 |
| Sum | $960,678 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @alin | |||
| @Andy Yeh Alpha | |||
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Cloud Play | @TechBull22 | @Ru-Ting Yeh | @Syl_will |
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
Top 20 favorite stocks
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| $PSX | |||
2018-10-13 10:44:00 Saturday ET
Dow Jones tumbles 3% or 831 points while NASDAQ tanks 4%, and this negative investor sentiment rips through most European and Asian stock markets in early-O
2018-04-17 12:38:00 Tuesday ET
Value investment strategies make investors wiser like water with core fundamental factor analysis. Value investors tend to buy stocks below their intrinsic
2025-05-21 04:27:10 Wednesday ET
Carol Dweck describes, discusses, and delves into the scientific reasons why the growth mindset often helps motivate individuals, teams, and managers to acc
2017-12-14 12:41:00 Thursday ET
Federal Reserve raises the interest rate by 25 basis points to the target range of 1.25% to 1.5% as FOMC members revise up their GDP estimate from 2% to 2.5
2019-04-21 10:07:54 Sunday ET
Central bank independence remains important for core inflation containment in the current age of political populism. In accordance with the dual mandate of
2024-05-05 10:31:00 Sunday ET
Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its